Population-level seropositivity trend for SARS-Cov-2 in Rio Grande do Sul, Brazil브라질 Rio Grande do Sul에서 SARS-Cov-2에 대한 인구 수준 혈청 양성 경향Original Article Published on 2021-11-082022-09-12 Journal: Revista de Saúde Pública [Category] MERS, SARS, 진단, [키워드] Affect Antibody test asked Brazil conducted COVID-19, epidemiology ELISA test Evolution group Guangzhou Guangzhou, China Health Surveys herd immunity highest identify IgG Immunity Immunity, Herd individual Infection lowest Perspective population groups Prevalence principal components analysis proportion Randomly Region Rio Grande SARS-CoV-2 selected Seroepidemiologic studies Seropositivity social distancing Socioeconomic Factors state Test viral S protein [DOI] 10.11606/s1518-8787.2021055004075 PMC 바로가기 [Article Type] Original Article
SARS-CoV-2 IgG seropositivity in a cohort of 449 non-hospitalized individuals during Spanish COVID-19 lockdownSARS-COV-2 IgG 혈청 양성 스페인 Covid-19 Lockdown 동안 449 명의 비 병원 된 개인의 코호트에서Article Published on 2021-11-032022-09-01 Journal: Scientific Reports [Category] MERS, SARS, 진단, 치료기술, [키워드] Ageusia analyzed Anosmia asthenia caused Characteristics Cohort comparable compatible symptoms Contact contact with coronavirus coronavirus disease COVID-19 COVID-19 patient described employment Epidemiology feature Fever Frequency Government Health care health care workers Hospitalized IgG individual Infection intrinsic lockdown manifestation Measures medical prescription Mobility National observational study odynophagia pandemic participant performed police positive Positive test RT-PCR SARS-CoV-2 SARS-CoV-2 IgG SARS-CoV-2 seroprevalence Serological testing Seropositivity Spanish Spread Symptom Symptoms symptoms of COVID-19 tested these symptoms viral infection [DOI] 10.1038/s41598-021-00990-4 PMC 바로가기 [Article Type] Article
SARS-CoV-2 seroprevalence in healthcare workers in a high-volume ophthalmology centre in Guatemala과테말라에있는 대량 안과 센터에서 의료 종사자의 SARS-Cov-2 SeroprevalenceResearch Article Published on 2021-11-022022-09-01 Journal: Annals of Medicine [Category] SARS, 바이오마커, 진단, [키워드] 95% CI age anti-SARS-CoV-2 antibodies antibodies antibody collected community transmission comparable conducted COVID-19 cross demographic characteristics determine Elecsy Factor females FIVE Gender groups HCW healthcare healthcare worker Healthcare workers high risk higher risk immunoassay Infection Logistic regression majority Nurses ophthalmology Patient positive Prevalence Probability reactive reported Result risk Roche SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-CoV-2 seroprevalence Seropositivity Seroprevalence serum sample serum samples tested total antibodies total antibody was used were given [DOI] 10.1080/07853890.2021.1993325 PMC 바로가기 [Article Type] Research Article
Seroprevalence and risk factors of COVID-19 in healthcare workers from 11 African countries: a scoping review and appraisal of existing evidenceReview Published on 2021-11-022022-10-31 Journal: Health policy and planning [Category] COVID-19, COVID19(2023년), SARS, [키워드] acute respiratory syndrome Africa African article coronavirus coronavirus disease country COVID-19 COVID-19 pandemic database Evidence extension gynaecology HCW HCWs Health professionals Health Service healthcare worker Infection Infection prevention item measure Older age pandemic peer-reviewed public health ranged Reporting resource review risk factor Risk factors SARS-CoV-2 SARS-CoV-2 seroprevalence scoping review searched serological data Seropositivity Seroprevalence systematic review the SARS-CoV-2 Vaccine [DOI] 10.1093/heapol/czab133 PMC 바로가기 [Article Type] Review
Longitudinal Follow Up of Immune Responses to SARS-CoV-2 in Health Care Workers in Sweden With Several Different Commercial IgG-Assays, Measurement of Neutralizing Antibodies and CD4 + T-Cell Responses다양한 상업용 IgG 분석, 중화 항체 측정 및 CD4 + T-세포 반응을 사용한 스웨덴 의료 종사자의 SARS-CoV-2에 대한 면역 반응의 종단적 추적Immunology Published on 2021-11-022022-09-11 Journal: Frontiers in Immunology [Category] MERS, SARS, 진단, 치료법, 치료제, [키워드] Abbot activated Analysis antibodies Architect blood donor Blood donors Care CD4 CD4+ T cells Cell correlation COVID-19 COVID-19 patient COVID-19 patients defined determine DiaSorin domain finding FIVE flow cytometric HCW HCWs Health care Health care worker health care workers iFlash IgG antibodies IgG antibody Immunological response in vitro individuals infected with SARS-CoV-2 Infection Infectious disease Infectious diseases longitudinal measurement membrane Mild moderate NAb NAbs naïve individuals Neutralizing antibodies neutralizing antibody nucleocapsid overlapping pandemic peptide peptide pools performed proportion reactivity recruited response risk S1/S2 SARS-CoV-2 SARS-COV-2 infection sensitivity serological Seropositivity Seroprevalence Sex spike Stimulation Swedish T-cell target Variation were measured worker [DOI] 10.3389/fimmu.2021.750448 PMC 바로가기 [Article Type] Immunology
SARS-CoV-2 antibodies started to decline just four months after COVID-19 infection in a paediatric populationSARS-CoV-2 항체는 소아 인구에서 COVID-19 감염 후 4개월 만에 감소하기 시작했습니다Article Published on 2021-11-012022-09-12 Journal: Acta paediatrica (Oslo, Norway : 1992) [Category] MERS, SARS, 진단, [키워드] acute respiratory syndrome age antibody antibody levels Antibody testing Antibody titre Asymptomatic asymptomatic infection blood test center children cohort study coronavirus COVID-19 infection cross-sectional eligible evaluated had no Immunity Infection infection rates initial interquartile range intravenous access Jerusalem male not affect Older Patient patients Population Prevalence required SARS-CoV-2 SARS-CoV-2 antibody School School closures seropositive Seropositivity tested [DOI] 10.1111/apa.16031 PMC 바로가기 [Article Type] Article
Emergence of SARS-CoV-2 Alpha (B.1.1.7) variant, infection rates, antibody seroconversion and seroprevalence rates in secondary school students and staff: Active prospective surveillance, December 2020 to March 2021, EnglandSARS-CoV-2 Alpha(B.1.1.7) 변이형의 출현, 중고등학생 및 교직원의 감염률, 항체 혈청 전환율 및 혈청 유병률: 적극적인 전향적 감시, 2020년 12월 ~ 2021년 3월, 영국Article Published on 2021-11-012022-09-11 Journal: The Journal of Infection [Category] MERS, SARS, 변종, 진단, [키워드] antibody B.1.1.7 blood sample Blood samples Community emergence England Evidence evidence of Infection infection rates initiated laboratory-confirmed SARS-CoV-2 infection nasal swab nasal swabs nucleoprotein participant Prevalence provided Region RT-PCR SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-COV-2 infection SARS-CoV-2 surveillance School secondary school secondary schools Seroconversion seroconversion rate seroconverted Seropositivity Seroprevalence Surveillance Vaccine-induced immunity variant Weekly [DOI] 10.1016/j.jinf.2021.08.019 PMC 바로가기 [Article Type] Article
COVID-19 vaccines in adult cancer patients with solid tumours undergoing active treatment: Seropositivity and safety. A prospective observational study in ItalyResearch article Published on 2021-11-012022-10-05 Journal: European journal of cancer (Oxford, England : 1990 [Category] SARS, 치료법, [키워드] administration antibodies antibody anticancer anticancer treatment baseline BNT162b2 Cancer cancer patient Cancer patients cancer progression composed conducted consecutive patient control group coronavirus disease COVID-19 COVID-19 antibody COVID-19 infection COVID-19 pandemic COVID-19 vaccination COVID-19 vaccine evaluate evaluated Factor GRADE healthy volunteers high risk IgG IgG titer immunogenic Italy Male sex median median age metastatic disease Patient prospective observational study receive reported Result RNA-1273 safety profile SARS-CoV-2 second dose secondary Seroconversion Seropositivity serum sample Side-effects significantly lower solid cancer solid tumour the vaccine therapy Treatment tumour two-dose regimen vaccination Vaccine vaccine dose were excluded [DOI] 10.1016/j.ejca.2021.08.035 [Article Type] Research article
Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort스페인 HIV 연구 네트워크 코호트에서 SARS-CoV-2 혈청 양성과 관련된 유병률 및 요인Review Published on 2021-11-012022-09-11 Journal: Clinical microbiology and infection : the official [Category] 치료제, [키워드] 95%CI acquisition acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 adjusted adjusted odds ratio age AIDS Analysis antiretroviral drug Antiretroviral therapy Asymptomatic backbone Birth Cancer carried CD4+ cell count chronic heart disease Chronic kidney disease cirrhosis Cohort collected Comorbidities Comorbidity coronavirus coronavirus disease Coronavirus disease 2019 country COVID-19 criteria cross-sectional cross-sectional study diabetes Diabetes Mellitus emtricitabine Factor fumarate heart disease HIV hypertension identify illness Illness severity increased the risk Infection inhibitor Kidney disease Latin Logistic regression analysis males median median age medical record medical records Multivariable logistic regression analysis network NIH nucleoside nucleotide other variables participant people with HIV plasma predictor Prevalence Prevent reverse transcriptase route sample collection SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-COV-2 infection SARS-CoV-2 infections serology Seropositivity Seroprevalence severe acute respiratory syndrome Coronavirus severity Sex Spain Spanish TDF/FTC tenofovir Tenofovir alafenamide tenofovir disoproxil tenofovir disoproxil fumarate therapy transcriptase undetectable variable Viral load was used [DOI] 10.1016/j.cmi.2021.06.023 PMC 바로가기 [Article Type] Review
High seroprevalence of SARS-CoV-2 but low infection fatality ratio eight months after introduction in Nairobi, KenyaSARS-CoV-2의 높은 혈청 유병률, 케냐 나이로비 도입 8개월 후 낮은 감염 치사율Article Published on 2021-11-012022-09-12 Journal: International Journal of Infectious Diseases [Category] MERS, SARS, 진단, [키워드] 95% CI adjusted antibody calculated conducted COVID-19 COVID-19 pandemic cross-sectional survey deaths Disease underreporting eight enrolled estimate Europe expected Factors fatality IFR individual individuals Infection Infection underestimation infections Kenya morbidity and mortality over positive random reported SARS-CoV-2 SARS-COV-2 infection Seropositivity Seroprevalence sub-Saharan Africa Surveillance tested the epidemic Transmission USA [DOI] 10.1016/j.ijid.2021.08.062 PMC 바로가기 [Article Type] Article